Trial Starts In Pfizer's Norvasc Patent Dispute
U.S. District Judge Terrence McVerry is presiding over the trial, which is expected to last over a week.
At the heart of the long-awaited trial is the lawsuit Pfizer brought against Mylan in 2002.
Filed two months after Mylan applied to the U.S. Food and Drug Administration for permission to sell a generic version of Norvasc, the suit alleged the Pennsylvania-based generics...
To view the full article, register now.